, Tracking Stock Market Picks
Enter Symbol:
Cubist Pharmaceuticals, Inc. (CBST) [hlAlert]

up 55.53 %

Cubist Pharmaceuticals, Inc. (CBST) upgraded to Buy with price target $70 by Aegis Capital

Posted on: Thursday,  Aug 1, 2013  11:25 AM ET by Aegis Capital

Aegis Capital rated Buy Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) on 08/01/2013, when the stock price was $65.13. Since
then, Cubist Pharmaceuticals, Inc. has gained 55.54% as of 01/16/2015's recent price of $101.30.
If you would have followed this Aegis Capital's recommendation on CBST, you would have gained 55.53% of your investment in 533 days.

Cubist Pharmaceuticals, Inc. is a biopharmaceutical company focused on the research, development and commercialization of pharmaceutical products that address unmet medical needs in the acute care environment. In the U.S., Cubist markets CUBICIN, the first antibiotic in a new class of antiinfectives called lipopeptides. The Cubist product pipeline includes our lipopeptide program and our natural products screening program. Cubist is headquartered in Lexington, MA.

Aegis Capital
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
1/24/2014 9:25 AM Buy
73.21 85.00
as of 12/13/2013
1 Week down  -3.62 %
1 Month up  0.36 %
3 Months down  -3.10 %
1 YTD down  -3.60 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
8/1/2013 11:25 AM Buy
65.13 70.00
2/6/2013 10:25 AM Hold
43.50 45.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy